Calculate your body mass index (BMI)
Study Dates: TBD - TBD
Up to: $2,240
Male, Female, Smoker, Non-Smoker
The Baltimore Early Phase Unit is currently seeking volunteers with palmoplantar pustulosis (PPP) to participate in an outpatient clinical research trial evaluating a new investigational drug. The study involves 1 screening visit, 4 doses of the investigational medication (approximately every 2 weeks), and 10 outpatient visits. You may be randomized to receive the study medication or placebo. Qualified participants must have a current diagnosis of PPP (for at least 6 months) and have active lesions on the palms and/or soles. Additionally, participants must be able and willing to washout of topical medicated treatments (i.e. Clobex) for 14 days and other systemic or biologic treatments (i.e. prescription medication such as Enbrel, Remicade, etc.) for 28 days-3 months (depending on the medication).